(Approval lapsed) TRULICITY dulaglutide 1.5 mg/0.5 mL solution for injection prefilled pen (Switzerland)
Type 2 Diabetes Mellitus: glycaemic control-
TRULICITY is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:
- As monotherapy
- In combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control.
Type 2 Diabetes Mellitus: reduction in risk of major adverse cardiovascular events -
TRULICITY is indicated as an adjunct to standard of care therapy to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus who have:
- established cardiovascular disease or
- multiple cardiovascular risk factors
![Picture of TRULICITY dulaglutide 1.5 mg/0.5 mL solution for injection prefilled pen](/sites/default/files/styles/full_lg/public/2024-02/trulicity-dulaglutide-1.5_mg_0.5_ml-solution-for-injection-prefilled-pen-carton.png?itok=fYqxvGFE)